<style type="text/css"> .wpb_animate_when_almost_visible { opacity: 1; }</style>

INVESTOR RELATIONS

Maxim Group Upgrades Trovagene from "Hold" to "Buy"

Revised model factoring in PCM-075 (AML drug) as the key driver of the company going forward - sets $4 target price.

Apr 13, 2017


PDF
email print rss pdf